Selective cytotoxicity of Portuguese Propolis ethyl acetate fraction towards renal cancer cells
Freitas, Ana Sofia and Costa, Marta and Pontes, Olívia and Seidel, Veronique and Proença, Fernanda and Cardoso, Susana M. and Oliveira, Rui and Baltazar, Fátima and Almeida-Aguiar, Cristina (2022) Selective cytotoxicity of Portuguese Propolis ethyl acetate fraction towards renal cancer cells. Molecules, 27 (13). 4001. ISSN 1420-3049 (https://doi.org/10.3390/molecules27134001)
Preview |
Text.
Filename: Freitas_etal_Molecules_2022_Selective_cytotoxicity_of_Portuguese_Propolis_ethyl_acetate_fraction_towards_renal_cancer_cells.pdf
Final Published Version License: Download (911kB)| Preview |
Abstract
Renal cell carcinoma is the most lethal cancer of the urological system due to late diagnosis and treatment resistance. Propolis, a beehive product, is a valuable natural source of compounds with bioactivities and may be a beneficial addition to current anticancer treatments. A Portuguese propolis sample, its fractions (n-hexane, ethyl acetate, n-butanol and water) and three subfractions (P1–P3), were tested for their toxicity on A498, 786-O and Caki-2 renal cell carcinoma cell lines and the non-neoplastic HK2 kidney cells. The ethyl acetate fraction showed the strongest toxicity against A498 (IC50 = 0.162 µg mL−1 ) and 786-O (IC50 = 0.271 µg mL−1 ) cells. With similar toxicity against 786-O, P1 (IC50 = 3.8 µg mL−1 ) and P3 (IC50 = 3.1 µg mL−1 ) exhibited greater effect when combined (IC50 = 2.5 µg mL−1 ). Results support the potential of propolis and its constituents as promising coadjuvants in renal cell carcinoma treatment.
ORCID iDs
Freitas, Ana Sofia, Costa, Marta, Pontes, Olívia, Seidel, Veronique ORCID: https://orcid.org/0000-0003-3880-5261, Proença, Fernanda, Cardoso, Susana M., Oliveira, Rui, Baltazar, Fátima and Almeida-Aguiar, Cristina;-
-
Item type: Article ID code: 81535 Dates: DateEvent22 June 2022Published22 June 2022Published Online14 June 2022AcceptedSubjects: Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
Medicine > Therapeutics. Pharmacology
Science > Chemistry
Science > MicrobiologyDepartment: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 21 Jul 2022 13:40 Last modified: 11 Nov 2024 13:33 URI: https://strathprints.strath.ac.uk/id/eprint/81535